Cardinal Capital Management Lifted Its Sun Life Financial (SLF) Position; Last Week Accuray (ARAY) Analysts

Cardinal Capital Management Inc increased Sun Life Financial Inc. (SLF) stake by 1.55% reported in 2017Q3 SEC filing. Cardinal Capital Management Inc acquired 21,606 shares as Sun Life Financial Inc. (SLF)’s stock declined 12.84%. The Cardinal Capital Management Inc holds 1.41M shares with $56.10 million value, up from 1.39 million last quarter. Sun Life Financial Inc. now has $25.01B valuation. The stock increased 0.63% or $0.26 during the last trading session, reaching $41.38. About 1.04M shares traded or 128.41% up from the average. Sun Life Financial Inc. (NYSE:SLF) has declined 1.22% since February 7, 2017 and is downtrending. It has underperformed by 17.92% the S&P500.

Among 9 analysts covering Accuray (NASDAQ:ARAY), 4 have Buy rating, 3 Sell and 2 Hold. Therefore 44% are positive. Accuray had 25 analyst reports since August 5, 2015 according to SRatingsIntel. BTIG Research maintained the stock with “Neutral” rating in Friday, August 21 report. RBC Capital Markets maintained Accuray Incorporated (NASDAQ:ARAY) on Friday, September 29 with “Hold” rating. RBC Capital Markets initiated the stock with “Sector Perform” rating in Tuesday, December 22 report. Cowen & Co initiated the shares of ARAY in report on Tuesday, September 13 with “Outperform” rating. The rating was maintained by RBC Capital Markets with “Hold” on Tuesday, May 30. The firm has “Hold” rating by RBC Capital Markets given on Wednesday, January 24. Citigroup initiated the shares of ARAY in report on Thursday, November 12 with “Sell” rating. As per Wednesday, August 23, the company rating was maintained by RBC Capital Markets. The company was maintained on Monday, September 25 by Jefferies. The firm has “Sell” rating by J.P. Morgan given on Wednesday, December 13. See Accuray Incorporated (NASDAQ:ARAY) latest ratings:

24/01/2018 Broker: RBC Capital Markets Rating: Hold New Target: $6.0 Maintain
23/01/2018 Broker: Jefferies Rating: Buy New Target: $7.0 Maintain
13/12/2017 Broker: J.P. Morgan Rating: Sell Downgrade
13/12/2017 Broker: JP Morgan Old Rating: Neutral New Rating: Underweight Old Target: $6 Downgrade
30/11/2017 Broker: Lake Street Rating: Buy New Target: $10 Initiates Coverage On
02/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $5.0 Maintain
29/09/2017 Broker: RBC Capital Markets Rating: Hold New Target: $5.0 Maintain
25/09/2017 Broker: Jefferies Rating: Buy New Target: $6.0 Maintain
22/08/2017 Broker: BTIG Research Rating: Hold Maintain
23/08/2017 Broker: RBC Capital Markets Rating: Hold New Target: $5.0 Maintain

Investors sentiment increased to 1.23 in 2017 Q3. Its up 0.19, from 1.04 in 2017Q2. It increased, as 13 investors sold Accuray Incorporated shares while 26 reduced holdings. 19 funds opened positions while 29 raised stakes. 63.77 million shares or 1.78% more from 62.66 million shares in 2017Q2 were reported. 7,172 are owned by Royal National Bank Of Canada. Prelude Cap Management Limited Liability Company accumulated 8,205 shares. 27,759 were accumulated by Aperio Gp Ltd Liability. Citigroup Inc has invested 0% in Accuray Incorporated (NASDAQ:ARAY). State Board Of Administration Of Florida Retirement System accumulated 71,909 shares. Spark Invest Llc reported 670,400 shares. 8,998 are held by Tower Rech Limited Liability Company (Trc). Amalgamated Bancshares reported 0% stake. Great West Life Assurance Can owns 0% invested in Accuray Incorporated (NASDAQ:ARAY) for 5,069 shares. Dimensional Fund Advisors Limited Partnership has 0% invested in Accuray Incorporated (NASDAQ:ARAY). Tiaa Cref Inv Mgmt Llc holds 0% of its portfolio in Accuray Incorporated (NASDAQ:ARAY) for 255,812 shares. Georgia-based Advisory Network Lc has invested 0.01% in Accuray Incorporated (NASDAQ:ARAY). Geode Mngmt Limited Com holds 724,747 shares or 0% of its portfolio. Natixis invested 0% in Accuray Incorporated (NASDAQ:ARAY). Lpl Financial Ltd Liability invested 0% of its portfolio in Accuray Incorporated (NASDAQ:ARAY).

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company has market cap of $441.39 million. The firm offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. It currently has negative earnings. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally.

The stock decreased 1.43% or $0.075 during the last trading session, reaching $5.175. About 1.34 million shares traded or 0.11% up from the average. Accuray Incorporated (NASDAQ:ARAY) has declined 21.41% since February 7, 2017 and is downtrending. It has underperformed by 38.11% the S&P500.

Since October 4, 2017, it had 0 buys, and 1 sale for $419,881 activity. $419,881 worth of stock was sold by Londy Kelly on Wednesday, October 4.